Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
35.2M
-
Shares change
-
-105K
-
Total reported value, excl. options
-
$1.31B
-
Value change
-
-$15.3M
-
Put/Call ratio
-
0.3
-
Number of buys
-
111
-
Number of sells
-
-146
-
Price
-
$37.13
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2024
313 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2024.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.2M shares
of 46.4M outstanding shares and own 75.86% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.12M shares), VANGUARD GROUP INC (2.71M shares), TD ASSET MANAGEMENT INC (1.84M shares), STATE STREET CORP (1.6M shares), NEUBERGER BERMAN GROUP LLC (1.37M shares), Pacer Advisors, Inc. (1.35M shares), DIMENSIONAL FUND ADVISORS LP (1.2M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.13M shares), Epoch Investment Partners, Inc. (1.1M shares), and Boston Trust Walden Corp (979K shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.